Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$28M Sell
389,051
-579,621
-60% -$54.6M 0.04% 348
2026
Q1
$115M Buy
968,672
+34,667
+4% +$4.29M 0.19% 98
2025
Q4
$118M Sell
934,005
-57,246
-6% -$7.47M 0.2% 98
2025
Q3
$145M Buy
991,251
+546,421
+123% +$82.6M 0.26% 71
2025
Q2
$69.4M Sell
444,830
-167,790
-27% -$26.6M 0.14% 147
2025
Q1
$101M Buy
612,620
+73,875
+14% +$12.3M 0.24% 85
2024
Q4
$87.8M Sell
538,745
-52,451
-9% -$9.38M 0.23% 92
2024
Q3
$116M Buy
591,196
+10,083
+2% +$1.86M 0.3% 63
2024
Q2
$101M Buy
581,113
+241,970
+71% +$40.3M 0.28% 68
2024
Q1
$57.4M Buy
339,143
+9,063
+3% +$1.7M 0.19% 107
2023
Q4
$65.1M Buy
330,080
+29,727
+10% +$5.26M 0.23% 84
2023
Q3
$52.3M Sell
300,353
-15,033
-5% -$2.73M 0.22% 82
2023
Q2
$54.3M Sell
315,386
-17,321
-5% -$2.99M 0.22% 85
2023
Q1
$55.4M Sell
332,707
-7,474
-2% -$1.22M 0.25% 71
2022
Q4
$49.9M Buy
340,181
+86,254
+34% +$12.8M 0.25% 78
2022
Q3
$37.7M Buy
253,927
+40,922
+19% +$6.84M 0.22% 91
2022
Q2
$36.6M Buy
213,005
+39,722
+23% +$6.87M 0.19% 97
2022
Q1
$32.7M Sell
173,283
-30,486
-15% -$6.03M 0.16% 124
2021
Q4
$49.7M Buy
203,769
+3,425
+2% +$750K 0.21% 100
2021
Q3
$38.9M Sell
200,344
-22,627
-10% -$4.57M 0.17% 127
2021
Q2
$41.6M Sell
222,971
-62,396
-22% -$10.8M 0.18% 122
2021
Q1
$44.9M Buy
285,367
+9,521
+3% +$1.51M 0.22% 99
2020
Q4
$45.7M Buy
275,846
+86,240
+45% +$14M 0.24% 93
2020
Q3
$31.4M Sell
189,606
-5,070
-3% -$779K 0.18% 106
2020
Q2
$26.7M Buy
194,676
+26,221
+16% +$3.42M 0.17% 114
2020
Q1
$19.8M Buy
168,455
+160
+0.1% +$21.1K 0.15% 131
2019
Q4
$22.3M Sell
168,295
-756
-0.4% -$93.9K 0.13% 147
2019
Q3
$21.1M Sell
169,051
-9,827
-5% -$1.19M 0.14% 141
2019
Q2
$20.3M Sell
178,878
-4,360
-2% -$457K 0.14% 148
2019
Q1
$18.4M Sell
183,238
-48,657
-21% -$4.42M 0.12% 165
2018
Q4
$19.8M Sell
231,895
-677,210
-74% -$61M 0.15% 146
2018
Q3
$83.2M Sell
909,105
-10,151
-1% -$901K 0.46% 56
2018
Q2
$78.3M Sell
919,256
-282,010
-23% -$23.8M 0.46% 47
2018
Q1
$100M Buy
1,201,266
+242,301
+25% +$19.1M 0.61% 35
2017
Q4
$69.1M Sell
958,965
-620
-0.1% -$42.6K 0.39% 56
2017
Q3
$61.2M Buy
959,585
+2,100
+0.2% +$132K 0.33% 69
2017
Q2
$59.7M Buy
957,485
+18,680
+2% +$1.1M 0.33% 66
2017
Q1
$50.1M Buy
938,805
+378,216
+67% +$20.4M 0.29% 80
2016
Q4
$30M Sell
560,589
-34,101
-6% -$1.73M 0.18% 131
2016
Q3
$30.9M Sell
594,690
-29,065
-5% -$1.47M 0.19% 111
2016
Q2
$29.6M Buy
623,755
+369,132
+145% +$17.4M 0.2% 111
2016
Q1
$11.3M Buy
254,623
+3,738
+1% +$159K 0.08% 261
2015
Q4
$12M Sell
250,885
-461
-0.2% -$20.8K 0.09% 248
2015
Q3
$10.3M Sell
251,346
-7,085
-3% -$329K 0.09% 259
2015
Q2
$12.5M Sell
258,431
-8,200
-3% -$391K 0.09% 248
2015
Q1
$12.3M Buy
266,631
+63,591
+31% +$2.87M 0.08% 272
2014
Q4
$8.74M Buy
203,040
+590
+0.3% +$23.9K 0.07% 332
2014
Q3
$7.48M Sell
202,450
-170
-0.1% -$5.82K 0.06% 367
2014
Q2
$6.54M Buy
202,620
+7,960
+4% +$244K 0.05% 420
2014
Q1
$5.63M Buy
+194,660
New +$5.95M 0.05% 427

Other funds holding ZTS

Aviva's ZTS Position: Q2 2026 in Review

Aviva reduced its Zoetis (ZTS) stake by 60% in Q2 2026, selling an estimated $54.6M and leaving 389,051 shares worth $28M. The position accounts for 0.04% of the portfolio, ranked #348.

Aviva first reported a position in ZTS in Q1 2014 and has held it in 50 quarters since. The position peaked at $145M in Q3 2025. 1,422 funds tracked by Wall St. Rank hold ZTS as of Q2 2026.

  • Aviva held 389,051 shares of Zoetis worth $28M as of Q2 2026.
  • Aviva sold 579,621 Zoetis shares in Q2 2026, an estimated $54.6M.
  • Zoetis made up 0.04% of Aviva's portfolio in Q2 2026, its #348 holding.
  • Aviva first reported a position in Zoetis in Q1 2014 and has held it in 50 quarters since.
  • Aviva's Zoetis position peaked at $145M in Q3 2025.
  • 1,422 funds tracked by Wall St. Rank held Zoetis as of Q2 2026.

Based on Aviva's 13F filing for Q2 2026, filed 13 Aug 2026.